Effects of Denosumab on Periprosthetic Bone After Total Hip Arthroplasty
NCT01630941
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
64
Enrollment
OTHER
Sponsor class
Conditions
Osteoarthritis, Hip
Ambulation Difficulty
Interventions
DRUG:
denosumab
Sponsor
Hans Mallmin